CencoraWBO:ABC -0.27%69 Market Cap is €49,000 Mil as of Jun. 26, 2026. GuruFocus rates WBO:ABC with a GF Score™ of 69/100 and a GF Value™ of €259.45 (Fairly Valued). The stock has 1 warning sign investors should review. Among 122 Medical Distribution companies, Cencora ranks better than 98.36% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Cencora's share price for the quarter that ended in Mar. 2026 was €269.7. Cencora's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 195 Mil. Therefore, Cencora's market cap for the quarter that ended in Mar. 2026 was €52,473 Mil.
Cencora's quarterly market cap
increased
from Sep. 2025 (€51,268 Mil) to Dec. 2025 (€56,217 Mil) but then
declined
from Dec. 2025 (€56,217 Mil) to Mar. 2026 (€52,473 Mil).
Cencora's annual market cap
increased
from Sep. 2023 (€34,532 Mil) to Sep. 2024 (€39,213 Mil) and
increased
from Sep. 2024 (€39,213 Mil) to Sep. 2025 (€51,268 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Cencora's Enterprise Value for Today is €58,148 Mil.
Cencora (WBO:ABC) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Cencora Market Cap Related Terms
Cencora Market Cap Historical Data
* Premium members only.
The historical data trend for Cencora's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Cencora's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cencora Market Cap vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Cencora's Market Cap distribution charts can be found below:
* The bar in red indicates where Cencora's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Cencora's Market Cap for the fiscal year that ended in Sep. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cencora (WBO:ABC) has a Market Cap of €49,000 Mil as of Jun. 26, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Cencora and its competitors. According to the industry distribution chart, Cencora ranks #2 out of 122 companies in the Medical Distribution industry, placing it in the top 1.6%.
Is Cencora's Market Cap too high?
Cencora's current Market Cap is €49,000 Mil. Based on the distribution chart, Cencora ranks #2 out of 122 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Cencora has a GF Score™ of 69/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Cencora's Market Cap compare to CAH and MCK?
According to the Medical Distribution industry distribution chart, Cencora ranks #2 out of 122 companies for Market Cap. This places Cencora in the top 2% of its industry — outperforming the majority of peers. The industry median Market Cap is 137.62. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Distribution company?
The median Market Cap among Medical Distribution companies is 137.62, based on 122 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Cencora and its competitors. For the Medical Distribution industry, the median Market Cap is 137.62 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cencora's current Market Cap is €49,000 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cencora stock overvalued right now?
Based on GuruFocus' analysis, Cencora (WBO:ABC) is currently considered Fairly Valued. The stock's GF Value™ is €259.45, compared to a current price of €254.30 — trading 2% below its estimated fair value. The current Market Cap is €49,000 Mil. Cencora's overall GF Score™ is 69/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Cencora (WBO:ABC), the current Market Cap is €49,000 Mil as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cencora (WBO:ABC) Overvalued in 2026?
Based on GuruFocus' analysis, Cencora stock appears to be undervalued.
The current stock price of €254.30 is trading 2% below its estimated GF Value™ of €259.45.
GuruFocus considers Cencora to be Fairly Valued.
Key valuation signals for WBO:ABC:
Market Cap: €49,000 Mil
GF Value™: €259.45 vs. price of €254.30 (2% below fair value)
No single metric tells the full story. See the WBO:ABC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
69GF Score
Get the complete analysis for WBO:ABC
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WBO:ABC has been successfully added to your 
